Coherus Oncology, Inc. Capital Expenditures
Coherus Oncology, Inc. (CHRS) reported Capital Expenditures of $286.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2024-03-15
- Coherus Oncology, Inc. payments to acquire property, plant, and equipment for the quarter ending 2023-12-31 was $34.00K, a 60.92% decline year-over-year.
- Coherus Oncology, Inc. payments to acquire property, plant, and equipment for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Coherus Oncology, Inc. payments to acquire property, plant, and equipment for the quarter ending 2023-06-30 was $100.00K, a 88.64% decline year-over-year.
- Coherus Oncology, Inc. payments to acquire property, plant, and equipment for the quarter ending 2023-03-31 was $152.00K, a 75.28% decline year-over-year.
- Coherus Oncology, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $286.00K, a 85.97% decline from fiscal 2022.
- Coherus Oncology, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $2.04M, a 58.18% increase from fiscal 2021.
- Coherus Oncology, Inc. payments to acquire property, plant, and equipment for fiscal 2021 was $1.29M, a 82.17% decline from fiscal 2020.
- Coherus Oncology, Inc. payments to acquire property, plant, and equipment for fiscal 2020 was $7.23M, a 296.87% increase from fiscal 2019.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2023-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $34.00K derived: sum of 2 quarters · filed 2024-03-15 | $134.00K derived: sum of 3 quarters · filed 2024-03-15 | $286.00K 10-K · filed 2024-03-15 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $100.00K derived: sum of 2 quarters · filed 2023-11-06 | $252.00K 10-Q · filed 2023-11-06 | $339.00K derived: sum of 4 quarters · filed 2024-03-15 |
| 2023-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $252.00K 10-Q · filed 2023-08-02 | $339.00K derived: sum of 3 quarters · filed 2024-03-15 | $796.00K derived: sum of 4 quarters · filed 2024-03-15 |
| 2023-03-31 | $152.00K 10-Q · filed 2023-05-08 | $239.00K derived: sum of 2 quarters · filed 2024-03-15 | $696.00K derived: sum of 3 quarters · filed 2024-03-15 | $1.58M derived: sum of 4 quarters · filed 2024-03-15 |
| 2022-12-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $544.00K derived: sum of 2 quarters · filed 2024-03-15 | $1.42M derived: sum of 3 quarters · filed 2024-03-15 | $2.04M 10-K · filed 2024-03-15 |
| 2022-09-30 | $457.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $1.34M derived: sum of 2 quarters · filed 2023-11-06 | $1.95M 10-Q · filed 2023-11-06 | $2.42M derived: sum of 4 quarters · filed 2024-03-15 |
| 2022-06-30 | $880.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $1.50M 10-Q · filed 2023-08-02 | $1.96M derived: sum of 3 quarters · filed 2024-03-15 | $2.22M derived: sum of 4 quarters · filed 2024-03-15 |
| 2022-03-31 | $615.00K 10-Q · filed 2023-05-08 | $1.08M derived: sum of 2 quarters · filed 2024-03-15 | $1.34M derived: sum of 3 quarters · filed 2024-03-15 | $1.76M derived: sum of 4 quarters · filed 2024-03-15 |
| 2021-12-31 | $468.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $729.00K derived: sum of 2 quarters · filed 2024-03-15 | $1.14M derived: sum of 3 quarters · filed 2024-03-15 | $1.29M 10-K · filed 2024-03-15 |
| 2021-09-30 | $261.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $676.00K derived: sum of 2 quarters · filed 2022-11-08 | $821.00K 10-Q · filed 2022-11-08 | $1.77M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $415.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $560.00K 10-Q · filed 2022-08-04 | $1.51M derived: sum of 3 quarters · filed 2023-03-06 | $3.62M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $145.00K 10-Q · filed 2022-05-05 | $1.10M derived: sum of 2 quarters · filed 2023-03-06 | $3.21M derived: sum of 3 quarters · filed 2023-03-06 | $5.59M derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $952.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $3.06M derived: sum of 2 quarters · filed 2023-03-06 | $5.45M derived: sum of 3 quarters · filed 2023-03-06 | $7.23M 10-K · filed 2023-03-06 |
| 2020-09-30 | $2.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $4.50M derived: sum of 2 quarters · filed 2021-11-08 | $6.28M 10-Q · filed 2021-11-08 | $6.67M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $4.17M 10-Q · filed 2021-08-05 | $4.55M derived: sum of 3 quarters · filed 2022-02-23 | $5.47M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | $1.78M 10-Q · filed 2021-05-06 | $2.17M derived: sum of 2 quarters · filed 2022-02-23 | $3.09M derived: sum of 3 quarters · filed 2022-02-23 | $3.27M derived: sum of 4 quarters · filed 2022-02-23 |
| 2019-12-31 | $387.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $1.30M derived: sum of 2 quarters · filed 2022-02-23 | $1.49M derived: sum of 3 quarters · filed 2022-02-23 | $1.82M 10-K · filed 2022-02-23 |
| 2019-09-30 | $918.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.10M derived: sum of 2 quarters · filed 2020-11-05 | $1.44M 10-Q · filed 2020-11-05 | $1.65M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $182.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $517.00K 10-Q · filed 2020-08-06 | $731.00K derived: sum of 3 quarters · filed 2021-02-25 | $1.22M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $335.00K 10-Q · filed 2020-05-07 | $549.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.04M derived: sum of 3 quarters · filed 2021-02-25 | $1.04M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $214.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $703.00K derived: sum of 2 quarters · filed 2021-02-25 | $708.00K derived: sum of 3 quarters · filed 2021-02-25 | $789.00K 10-K · filed 2021-02-25 |
| 2018-09-30 | $489.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $494.00K derived: sum of 2 quarters · filed 2019-11-08 | $575.00K 10-Q · filed 2019-11-08 | $684.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $86.00K 10-Q · filed 2019-08-05 | $195.00K derived: sum of 3 quarters · filed 2020-02-27 | $2.01M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $81.00K 10-Q · filed 2019-05-09 | $190.00K derived: sum of 2 quarters · filed 2020-02-27 | $2.00M derived: sum of 3 quarters · filed 2020-02-27 | $2.96M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $1.92M derived: sum of 2 quarters · filed 2020-02-27 | $2.88M derived: sum of 3 quarters · filed 2020-02-27 | $4.57M 10-K · filed 2020-02-27 |
| 2017-09-30 | $1.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $2.77M derived: sum of 2 quarters · filed 2018-11-08 | $4.46M 10-Q · filed 2018-11-08 | $8.03M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $961.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $2.65M 10-Q · filed 2018-08-08 | $6.22M derived: sum of 3 quarters · filed 2019-02-28 | $6.72M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $1.69M 10-Q · filed 2018-05-10 | $5.26M derived: sum of 2 quarters · filed 2019-02-28 | $5.76M derived: sum of 3 quarters · filed 2019-02-28 | $6.06M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $3.57M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $4.07M derived: sum of 2 quarters · filed 2019-02-28 | $4.37M derived: sum of 3 quarters · filed 2019-02-28 | $6.51M 10-K · filed 2019-02-28 |
| 2016-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $801.00K derived: sum of 2 quarters · filed 2017-11-06 | $2.95M 10-Q · filed 2017-11-06 | $4.39M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | $301.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $2.45M 10-Q · filed 2017-08-07 | $3.89M derived: sum of 3 quarters · filed 2018-03-08 | $6.29M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | $2.15M 10-Q · filed 2017-05-08 | $3.59M derived: sum of 2 quarters · filed 2018-03-08 | $5.99M derived: sum of 3 quarters · filed 2018-03-08 | $7.00M derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $3.84M derived: sum of 2 quarters · filed 2018-03-08 | $4.85M derived: sum of 3 quarters · filed 2018-03-08 | $6.16M 10-K · filed 2018-03-08 |
| 2015-09-30 | $2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $3.41M derived: sum of 2 quarters · filed 2016-11-09 | $4.72M 10-Q · filed 2016-11-09 | $5.21M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $2.32M 10-Q · filed 2016-08-09 | $2.81M derived: sum of 3 quarters · filed 2017-03-14 | $3.62M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | $1.31M 10-Q · filed 2016-05-09 | $1.80M derived: sum of 2 quarters · filed 2017-03-14 | $2.61M derived: sum of 3 quarters · filed 2017-03-14 | $3.90M derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | $489.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $1.30M derived: sum of 2 quarters · filed 2017-03-14 | $2.59M derived: sum of 3 quarters · filed 2017-03-14 | $2.85M 10-K · filed 2017-03-14 |
| 2014-09-30 | $807.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $2.10M derived: sum of 2 quarters · filed 2015-11-10 | $2.36M 10-Q · filed 2015-11-10 | $2.51M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $1.55M 10-Q · filed 2015-08-10 | $1.70M derived: sum of 3 quarters · filed 2016-02-29 | |
| 2014-03-31 | $260.00K 10-Q · filed 2015-05-11 | $408.00K derived: sum of 2 quarters · filed 2016-02-29 | ||
| 2013-12-31 | $148.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $373.00K 10-K · filed 2016-02-29 | ||
| 2013-09-30 | $225.00K 10-Q · filed 2014-12-15 | |||
| 2012-12-31 | $1.78M 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |